ID   HCe-8693
AC   CVCL_6909
SY   Hce-8693; HCE-8693; Hce8693; HCE8693
DR   CCRID; 3101HUMTCHu70
DR   Ubigene; YC-B090
DR   Wikidata; Q54881854
RX   PubMed=2634537;
RX   PubMed=7954969;
CC   Population: Chinese.
CC   Doubling time: 30.4 hours (PubMed=2634537).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=3101HUMTCHu70; Ubigene=YC-B090
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 14
ST   D21S11: 29,32.2
ST   D2S1338: 23,24
ST   D3S1358: 15,16
ST   D5S818: 11,15
ST   D7S820: 11
ST   D8S1179: 10,11
ST   FGA: 21,23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
RX   PubMed=2634537;
RA   Zhang, Zhong-Xian
RA   Qian, Li-Juan
RA   Zhang, Yi-Meng
RA   Xu, Shen-Hua
RA   Qian, Yong-Jin
RA   Huang, Xiao-Xi
RA   Dai, Hui-Fang
RT   "Establishment of a cell line (HCe-8693) from human undifferentiated
RT   adenocarcinoma of the cecum and its characterization.";
RL   Zhonghua Zhong Liu Za Zhi 11:413-415(1989).
//
RX   PubMed=7954969;
RA   Li, Shen-De
RA   Qian, Li-Juan
RA   Huang, Xiao-Shu
RT   "Cytogenetic studies on a human cecum adenocarcinoma cell line (HCe-8693).";
RL   Zhongguo Yi Xue Ke Xue Yuan Xue Bao 16:58-62(1994).
//